Kohei Shitara, Medical Oncologist at National Cancer Center Hospital East, Japan, shared a post on X:
“LEAP15 for gastric cancer did not meet OS endpoint. Drop of chemo or dose of LEN/toxicities matter? Need learn from negative trial.”
More posts featuring Kohei Shitara.